Marks Group Wealth Management, Inc Amgen Inc Transaction History

Marks Group Wealth Management, Inc

$1 Billion
Q3 2024

A detailed history of Marks Group Wealth Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 6,270 shares of AMGN stock, worth $1.65 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

6,270

Previous 6,306 0.57%

Holding current value

$1.65 Million

Previous $1.97 Million 2.54%

% of portfolio

0.2%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $11,137 - $12,145	-36 Reduced 0.57%	6,270 $2.02 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $326,335 - $396,583	-1,242 Reduced 16.45%	6,306 $1.97 Million
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $197,081 - $237,902	-733 Reduced 8.85%	7,548 $2.15 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $250,841 - $282,979	-981 Reduced 10.59%	8,281 $2.39 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $150,212 - $186,493	-687 Reduced 6.91%	9,262 $2.49 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $20,569 - $24,323	96 Added 0.97%	9,949 $2.21 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $327,847 - $399,590	1,452 Added 17.28%	9,853 $2.38 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $152,304 - $193,521	665 Added 8.6%	8,401 $2.21 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $189,668 - $213,911	845 Added 12.26%	7,736 $1.74 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $259,548 - $288,832	1,125 Added 19.51%	6,891 $1.68 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $367,277 - $406,304	1,675 Added 40.94%	5,766 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $194,504 - $222,592	978 Added 31.42%	4,091 $677,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $68,775 - $80,578	-324 Reduced 9.43%	3,113 $667,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $31,066 - $34,465	133 Added 4.03%	3,437 $840,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $42,384 - $49,392	191 Added 6.14%	3,304 $813,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $19,690 - $23,447	91 Added 3.01%	3,113 $716,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $5,631 - $6,262	24 Added 0.8%	3,022 $768,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $95,146 - $116,757	481 Added 19.11%	2,998 $712,000
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $85,652 - $113,599	-470 Reduced 15.73%	2,517 $509,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $565,170 - $726,438	2,987 New	2,987 $720,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.

Account

Marks Group Wealth Management, Inc Amgen Inc Transaction History